Exchange: OTC·Updated 11:28 AM EST

HLUBF H. Lundbeck AS - Ordinary Shares - Class A

$8.35
$0.41
(5.16%)
Today
EarningsFeb 10
Mkt Cap$8.28B
Vol150.00

About HLUBF

H. Lundbeck A/S engages in the research, development, production, and sale of pharmaceuticals for the treatment of psychiatric and neurological disorders. Its product portfolio targets the following diseases: Alzheimer's, depression, Parkinson's, Schizophrenia, alcohol dependence, anxiety, bipolar disorder, epilepsy, and Huntington's. It operates through the following geographical segments: Europe, United States, and International Operations. The company was founded by Hans Lundbeck on August 14, 1915 and is headquartered in Valby, Denmark.
50

Neutral Sentiment

How do you feel about HLUBF?

Advertisement|Remove ads.